Study of ADH-1 Given Intravenously to Patients With Solid Tumors

NCT00265057 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: ADH -1 (Exherin™)

Sponsor

Adherex Technologies, Inc.